Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Neurology|November 24, 2025
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying TreatmentsErmelinda De Meo, Ilaria Addazio, Emilio Portaccio, et al.
Neurology|September 22, 2025
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple SclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Journal of Neurology|May 28, 2024
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progressionEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.
Neurology and Therapy|February 18, 2026
Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE StudySilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Neurology and Therapy|May 24, 2026
Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) RiskSilvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, et al.
Annals of Neurology|April 26, 2017
Prognostic indicators in pediatric clinically isolated syndromePietro Iaffaldano, Marta Simone, Giuseppe Lucisano, et al.
JAMA Neurology|November 27, 2023
Multiple Sclerosis Progression and Relapse Activity in ChildrenPietro Iaffaldano, Emilio Portaccio, Giuseppe Lucisano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)Damiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.
Pageof 7